Drug Chatter -- Tracking biopharma stock chatter

Profile for Karyopharm Therapeutics Inc. (KPTI)

« Back to company index

KPTI Chatter Timeline

Stock Ticker for KPTI

Most Active Tweeters for KPTI

UserTweets
@confcalltran 7
@Biotech2050 6
@SleekMoneycom 5
@intercooleronli 5
@CFinancialNews 5

Recent Tweets for KPTI

SPNewsAnalysis @SPNewsAnalysis
Karyopharm Therapeutics Inc. Expected to Earn FY2020 Earnings of $0.02 Per Share $KPTI https://t.co/kzxssyglCp
September 23rd 2017, 12:09pm
Primiano @Primiano
RT @Karyopharm: $KPTI Appoints Michael Falvey as CFO, Adds Clinical Strategy & Human Resources Executives & Reports Inducement Grant https:…
September 23rd 2017, 12:09am
WatchlistN @WatchlistN
Karyopharm Therapeutics Inc. $KPTI Receives Average Rating of “Buy” from Brokerages https://t.co/JJKv1OWpYv
September 22nd 2017, 6:09pm
tom_mcdaniels @tom_mcdaniels
$kpti presenting at cantor on Monday. Expect updated roadmap and SEAL results
September 22nd 2017, 2:09pm
CFinancialNews @CFinancialNews
Wedbush Weighs in on Karyopharm Therapeutics Inc.’s FY2020 Earnings $KPTI https://t.co/jT3wWDAazo
September 22nd 2017, 1:09pm
intercooleronli @intercooleronli
Wedbush Weighs in on Karyopharm Therapeutics Inc.’s FY2020 Earnings $KPTI https://t.co/BlqBO1d7r9
September 22nd 2017, 1:09pm
finboxio @finboxio
Mirza (Director) sold 2,882 shares of $KPTI. Yes... stock's above fair value https://t.co/hkGT0txMYR https://t.co/6Fi6lDlaXW
September 22nd 2017, 1:09pm
1stOncology @1stOncology
Successful Outcome from Phase 2 Portion of Phase 2/3 SEAL Study Evaluating #Selinexor in #Liposarcoma $KPTI https://t.co/kH3qY4TT0b
September 22nd 2017, 10:09am
SleekMoneycom @SleekMoneycom
Karyopharm Therapeutics Inc. $KPTI Rating Reiterated by Cantor Fitzgerald https://t.co/Z2CEDweLMl
September 22nd 2017, 7:09am
storminvestor @storminvestor
Karyopharm Therapeutics Inc. $KPTI Rating Reiterated by Cantor Fitzgerald https://t.co/81qBGNut7Q
September 22nd 2017, 1:09am
SPNewsAnalysis @SPNewsAnalysis
Karyopharm Therapeutics Inc. $KPTI Rating Reiterated by Cantor Fitzgerald https://t.co/BlytfvP9s8
September 22nd 2017, 1:09am
SleekMoneycom @SleekMoneycom
Royal Bank Of Canada Initiates Coverage on Karyopharm Therapeutics Inc. $KPTI https://t.co/8aYagUQxK6
September 21st 2017, 5:09pm
kuritzmike @kuritzmike
RT @tgtxdough: LR $KPTI ahead of potentially registration-enabling Phase II results in "penta-refractory" multiple myeloma 1Q18. Raising PT…
September 21st 2017, 4:09pm
intercooleronli @intercooleronli
Karyopharm Therapeutics Inc. $KPTI Earns Buy Rating from Cantor Fitzgerald https://t.co/McAKiHYKRK
September 21st 2017, 3:09pm
CFinancialNews @CFinancialNews
Karyopharm Therapeutics Inc. $KPTI Earns Buy Rating from Cantor Fitzgerald https://t.co/QkpOs9f1zy
September 21st 2017, 3:09pm
TheMarketsDaily @TheMarketsDaily
Karyopharm Therapeutics’ $KPTI Buy Rating Reaffirmed at Cantor Fitzgerald https://t.co/9ldGaqltJr
September 21st 2017, 2:09pm
dakotafinancial @dakotafinancial
Karyopharm Therapeutics’ $KPTI Buy Rating Reaffirmed at Cantor Fitzgerald https://t.co/hXx0yB0nO9
September 21st 2017, 2:09pm
RatingsNetwork @RatingsNetwork
Karyopharm Therapeutics's buy rating reiterated at Cantor Fitzgerald. $18.00 PT. https://t.co/iu7Ud79agi $KPTI #KPTI
September 21st 2017, 2:09pm
Biotech2050 @Biotech2050
RT @tgtxdough: $KPTI KEY -STORM (penta-refractory MM) data Apr'18 w/ potential accelerated approval filing 2H18; final SADAL (DLBCL) analys…
September 21st 2017, 1:09pm
Biotech2050 @Biotech2050
RT @tgtxdough: $KPTI three KOL events KOLs with MM-focused backgrounds (scheduled for Sep 27th in Boston Oct 3rd in NYC), on Oct 17th in NY…
September 21st 2017, 1:09pm
tgtxdough @tgtxdough
$KPTI KEY -STORM (penta-refractory MM) data Apr'18 w/ potential accelerated approval filing 2H18; final SADAL (DLBCL) analysis expected 2H18
September 21st 2017, 1:09pm
tgtxdough @tgtxdough
$KPTI three KOL events KOLs with MM-focused backgrounds (scheduled for Sep 27th in Boston Oct 3rd in NYC), on Oct 17th in NYC).
September 21st 2017, 1:09pm
AvisolCapital @AvisolCapital
$KPTI positive results from phase 2/3 - https://t.co/YYSSaU3J5c
September 21st 2017, 11:09am
TheMarketsDaily @TheMarketsDaily
Karyopharm Therapeutics Inc. $KPTI SVP Sells $22,000.00 in Stock https://t.co/xsx1yzEr0G
September 21st 2017, 11:09am
emq_news @emq_news
Karyopharm Therapeutics Inc. $KPTI Director Sells $31,702.00 in Stock https://t.co/qpFgLWZNC0
September 21st 2017, 10:09am
elfaulder9 @elfaulder9
RT @ChimeraResearch: September 21 Biotech Update $FOLD $kpti https://t.co/CodpXurqlO
September 21st 2017, 9:09am
ChimeraResearch @ChimeraResearch
September 21 Biotech Update $FOLD $kpti https://t.co/CodpXurqlO
September 21st 2017, 9:09am
tradejas @tradejas
RT @BioStocks: $KPTI Announces Successful Outcome from Phase 2 Portion of Phase 2/3 SEAL Study Evaluating Selinexor https://t.co/t80IVdJpCQ
September 20th 2017, 9:09pm
BadGoldClothlng @BadGoldClothlng
RT @marketexclusive: Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Files An 8-K Financial Statements and Exhibits https://t.co/gXeXtmqWAw $KPTI
September 20th 2017, 8:09pm
marketexclusive @marketexclusive
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Files An 8-K Financial Statements and Exhibits https://t.co/gXeXtmqWAw $KPTI
September 20th 2017, 8:09pm
TickerReport @TickerReport
Karyopharm Therapeutics Inc. $KPTI Sees Strong Trading Volume https://t.co/oUmPT0iIo4
September 20th 2017, 7:09pm
emq_news @emq_news
Karyopharm Therapeutics Inc. $KPTI Sees Strong Trading Volume https://t.co/zwO4518RYp
September 20th 2017, 7:09pm
TickerReport @TickerReport
Karyopharm Therapeutics Inc. $KPTI Sees Strong Trading Volume https://t.co/3g6XdkLkSI
September 20th 2017, 7:09pm
realmaciej @realmaciej
RT @tgtxdough: JMP $KPTI PT 22 Selinexor for liposarcoma is not currently in our financial model. top-line Phase III SEAL results by the en…
September 20th 2017, 4:09pm
confcalltran @confcalltran
Karyopharm Therapeutics: Targeting Disease At The Nuclear Pore https://t.co/i4PdfPeS4r $KPTI
September 20th 2017, 4:09pm
tgtxdough @tgtxdough
JMP $KPTI PT 22 Selinexor for liposarcoma is not currently in our financial model. top-line Phase III SEAL results by the end of 2018
September 20th 2017, 2:09pm
tom_mcdaniels @tom_mcdaniels
$kpti next up #ash2017
September 20th 2017, 1:09pm
avidresearch @avidresearch
$KPTI PFS using WHO criteria doesn't look that impressive. HR of 0.84 just 16% reduction.
September 20th 2017, 11:09am
tstamm7002 @tstamm7002
$KPTI incapable of holding gains
September 20th 2017, 11:09am
Mahmissa @Mahmissa
Ha! Evidently 42 shares filled on my $kpti short at 11.90
September 20th 2017, 9:09am
SwingTradeBot @SwingTradeBot
Recent $KPTI technical alerts: Slingshot Bullish plus 2 more alerts... https://t.co/51Rgrexboy
September 20th 2017, 9:09am
StocksThatGo @StocksThatGo
ALERT: NEWS $KPTI Successful Outcome from Phase 2 Portion of Phase 2/3 SEAL Study Evaluating Selinexor in Patients with Previously Treated
September 20th 2017, 9:09am
1MinuteStock @1MinuteStock
Wondering about risks of $KPTI? The 63-day volatility is 22.22% https://t.co/CTFgRoQnqM
September 20th 2017, 9:09am
7LadyQ @7LadyQ
$KPTI Karyopharm's selinexor successful in mid-stage soft tissue cancer study; shares ahead 15% premarket
September 20th 2017, 9:09am
NewsToDesk @NewsToDesk
$KPTI: Karyopharm’s selinexor successful in mid-stage soft tissue cancer …: https://t.co/xoTQgVAzZ7
September 20th 2017, 9:09am
Anto_Casadei @Anto_Casadei
Karyopharm's selinexor successful in mid-stage soft tissue cancer study; shares ahead 15% premarket $KPTI https://t.co/nQBFieOkvL
September 20th 2017, 9:09am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Karyopharm's selinexor successful in mid-stage soft tissue cancer study; shares ahead 15% premarket https://t.co/upJE9wFaqE #premarket $KPTI
September 20th 2017, 9:09am
MarketCurrents @MarketCurrents
Karyopharm's selinexor successful in mid-stage soft tissue cancer study; shares ahead 15% premarket https://t.co/5InRdgBxSI #premarket $KPTI
September 20th 2017, 9:09am
MarketChmln @MarketChmln
$KPTI stock increases 14.1% in premarket, company press release at 7:00 AM https://t.co/gOJyOMG1ak
September 20th 2017, 9:09am
ARatings @ARatings
Karyopharm Therapeutics Received its Third Buy in a Row $KPTI https://t.co/xNdr2SdIyJ
September 20th 2017, 8:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.